Image of Neuroprotective Agents Conference 2004 Presentations page banner


Abstract Submission and Presentations

Each participant giving a platform presentation is expected to submit a manuscript, preferably

at the time of the conference - but no later than October 31, 2012.  Participants giving a poster

presentation may submit a manuscript if they so desire.  Both abstract and manuscript submissions

are subject to peer review.

 

Abstracts must be submitted as an email attachment: single-page Microsoft Word compatible
document (text < 350 words, 12-point font, Times New Roman preferred).  The title should be
boldface, and all authors’ affiliations included.  The email should include the corresponding and
presenting author’s contact information (email address, fax, phone).  Choice of platform or
poster presentation should be stated.

 

Platform presentations will be 15 min + 5 min for discussion.

All presentations should be limited to original work not previously published elsewhere.

 

Abstract deadline:                                                                          June 30, 2010 

 

Please send an e-mail with the abstract as an attachment in Microsoft Word to:  

        Russell Andrews (rja@russelljandrews.org)

        Tucker Patterson (tucker.patterson @fda.hhs.gov)

      

Please indicate your preference for either a poster or platform presentation on your abstract